M. Andrew Wade is CFO & VP at AtriCure, Inc. (ATRC). They have made 7 open-market trades across 1 company since 2017, most recently 2020-06-30.
CIK 0001560591
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ATRC | 140,537 | $7.9M |
Shares reported on the most recent Form 4, priced at the 2020-07-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ATRC | SELL | 2020-02-21 | 2020-02-24 | $39.46 | $1.2M | -1.7% | -23.9% | +27.2% |
| ATRC | SELL | 2020-01-16 | 2020-01-17 | $36.00 | $360K | +5.0% | +12.3% | -3.7% |
| ATRC | SELL | 2020-01-14 | 2020-01-16 | $34.00 | $340K | +8.0% | +16.6% | -0.5% |
| ATRC | SELL · 10b5-1 | 2019-12-26 | 2019-12-30 | $32.00 | $32K | +5.1% | +24.2% | +1.7% |
| ATRC | SELL | 2019-11-25 | 2019-11-26 | $30.00 | $351K | +1.4% | +7.0% | +28.0% |
| ATRC | SELL | 2019-06-04 | 2019-06-06 | $30.00 | $324K | +2.0% | +5.8% | -11.3% |
| ATRC | SELL | 2019-04-30 | 2019-05-01 | $30.00 | $296K | -1.9% | -1.1% | +8.7% |
| ATRC | SELL | 2017-11-30 | 2017-12-01 | $18.41 | $37K | -1.3% | -1.3% | -5.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.